87 related articles for article (PubMed ID: 477726)
1. Selective labelling of different dopamine receptors by a new agonist 3H-ligand: 3H-N-propylnorapomorphine.
Titeler M; Seeman P
Eur J Pharmacol; 1979 Jun; 56(3):291-2. PubMed ID: 477726
[No Abstract] [Full Text] [Related]
2. 3H-N-n-propylnorapomorphine: a novel agonist ligand for central dopamine receptors.
Creese I; Padgett L; Fazzini E; Lopez F
Eur J Pharmacol; 1979 Jul; 56(4):411-2. PubMed ID: 477735
[No Abstract] [Full Text] [Related]
3. Selective labeling of apomorphine receptors by 3H-LSD.
Whitaker PM; Seeman P
Eur J Pharmacol; 1979 Jun; 56(3):269-71. PubMed ID: 225177
[TBL] [Abstract][Full Text] [Related]
4. Dopamine receptors in subcellular fractions from bovine caudate: enrichment of [3H]spiperone binding in a postsynaptic membrane fraction.
Near JA; Mahler HR
J Neurochem; 1981 Mar; 36(3):1142-51. PubMed ID: 7205263
[No Abstract] [Full Text] [Related]
5. Antiparkinsonian drug doses and neuroleptic receptors.
Titeler M; Seeman P
Experientia; 1978 Nov; 34(11):1490-2. PubMed ID: 720482
[TBL] [Abstract][Full Text] [Related]
6. Differential labelling of dopamine receptors in rat brain in vivo: comparison of [3H]piribedil, [3H]S 3608 and [3H]N,n-propylnorapomorphine.
Hall MD; Jenner P; Marsden CD
Eur J Pharmacol; 1983 Jan; 87(1):85-94. PubMed ID: 6188621
[No Abstract] [Full Text] [Related]
7. Regional in vivo binding of [3H]N-propylnorapomorphine in the mouse brain. Evidence for labelling of central dopamine receptors.
Köhler C; Fuxe K; Ross SB
Eur J Pharmacol; 1981 Jul; 72(4):397-402. PubMed ID: 7274333
[TBL] [Abstract][Full Text] [Related]
8. Selective labeling of pre-synaptic receptors by 3H-dopamine, 3H-apomorphine and 3H-clonidine; labeling of post-synaptic sites by 3H-neuroleptics.
Titeler M; Tedesco JL; Seeman P
Life Sci; 1978 Aug; 23(6):587-91. PubMed ID: 29197
[No Abstract] [Full Text] [Related]
9. [3H]205-501, a non-catechol dopaminergic agonist, labels selectively and with high affinity dopamine D2 receptors.
Closse A; Frick W; Markstein R; Maurer R; Nordmann R
J Neural Transm; 1985; 62(3-4):231-48. PubMed ID: 3161996
[TBL] [Abstract][Full Text] [Related]
10. Similar binding of 3H-ADTN and 3H-apomorphine to calf brain dopamine receptors.
Seeman P; Woodruff GN; Poat JA
Eur J Pharmacol; 1979 Apr; 55(2):137-42. PubMed ID: 456412
[TBL] [Abstract][Full Text] [Related]
11. Autoradiographic localization and quantification of dopamine D2 receptors in normal human brain with [3H]N-n-propylnorapomorphine.
Camus A; Javoy-Agid F; Dubois A; Scatton B
Brain Res; 1986 Jun; 375(1):135-49. PubMed ID: 3719352
[TBL] [Abstract][Full Text] [Related]
12. Phenoxybenzamine treatment differentiates dopaminergic 3H-ligand binding sites in bovine caudate membranes.
Hamblin MW; Creese I
Mol Pharmacol; 1982 Jan; 21(1):44-51. PubMed ID: 6127621
[TBL] [Abstract][Full Text] [Related]
13. Heat treatment mimics guanosine-5'-triphosphate effects on dopaminergic 3H-ligand binding to bovine caudate membranes.
Hamblin MW; Creese I
Mol Pharmacol; 1982 Jan; 21(1):52-6. PubMed ID: 7132962
[TBL] [Abstract][Full Text] [Related]
14. Affinities of drugs for the agonist and antagonist states of the dopamine receptor.
Riddall DR; Leavens WJ
Eur J Pharmacol; 1978 Sep; 51(2):187-8. PubMed ID: 699984
[No Abstract] [Full Text] [Related]
15. Dopamine receptor binding in bovine intermediate lobe pituitary membranes.
Sibley DR; Creese I
Endocrinology; 1980 Nov; 107(5):1405-9. PubMed ID: 7428676
[TBL] [Abstract][Full Text] [Related]
16. Dopamine receptors, neuroleptics, and schizophrenia.
Snyder SH
Am J Psychiatry; 1981 Apr; 138(4):460-4. PubMed ID: 6111227
[TBL] [Abstract][Full Text] [Related]
17. [3H] spiroperidol binding to brain neurotransmitter receptors.
Withy RM; Mayer RJ; Strange PG
FEBS Lett; 1980 Apr; 112(2):293-5. PubMed ID: 6154601
[No Abstract] [Full Text] [Related]
18. Multiple receptors for brain dopamine.
Titeler M; Weinreich P; Sinclair D; Seeman P
Proc Natl Acad Sci U S A; 1978 Mar; 75(3):1153-6. PubMed ID: 418405
[TBL] [Abstract][Full Text] [Related]
19. Cholecystokinin peptides in vitro modulate the characteristics of the striatal 3H-N-propylnorapomorphine sites.
Agnati LF; Celani MF; Fuxe K
Acta Physiol Scand; 1983 May; 118(1):79-81. PubMed ID: 6312748
[No Abstract] [Full Text] [Related]
20. In vitro binding of the very potent and selective D-2 dopamine agonist, [3H]N-0437 to calf caudate membranes.
Van der Weide J; De Vries JB; Tepper PG; Horn AS
Eur J Pharmacol; 1987 Feb; 134(2):211-9. PubMed ID: 3569410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
